Immunogenicity
POSITIVE
Positive anti-drug antibody (ADA) was observed in 1 subject in each WBP216 30-mg group (at baseline and week 20), WBP216 150-mg group (at week 12, 16, 20, and 24), and WBP216 300-mg group (at baseline). Anti-drug antibodies were detected in only one subject after dosing, indicating an acceptable immunogenicity profile. In all these 3 subjects, C